Healio
Healio Minute
The latest health care news you need, when you need it. Only at Healio.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Neurology Edition: Top Headlines for Week of September 12, 2022 15.09.2022 12:15
In this edition, new cannabinoids hold promise for medical applications; Theranica secures $45 million for migraine treatment device and more. Read the full coverage here: Newly discovered cannabinoids hold promise for medical, pain applications Theranica secures $45 million to expand wearable migraine treatment device in US Implantable loop recorder screening for AF not linked to stroke reduction...
Lung Cancer Edition: Top Headlines for Week of September 12, 2022 14.09.2022 12:31
In this edition, germline testing 'should be considered' for all patients with lung cancer; phase 3 trial of canakinumab misses endpoint; sexual dysfunction common among women with lung cancer, and more. Read the full coverage here: Germline testing 'should be considered' for all patients with lung cancer, data suggest Phase 3 trial of canakinumab for non-small cell lung cancer misses endpoint Sex...
Breast Cancer Edition: Top Headlines for Week of September 5, 2022 09.09.2022 11:39
In this episode, VTE rate with abemaciclib (uh-bem-uh-cy-clib) higher in real-world setting; Enhertu extends progression-free survival in patient subgroup; FDA grants priority review to elacestrant (ee-las-cess-trant) for metastatic disease; and more. Read the full coverage here: VTE rate with abemaciclib higher in real-world setting among patients with breast cancer Enhertu extends progression-fr...
Neurology Edition: Top Headlines for Week of September 5, 2022 08.09.2022 9:33
In this edition, blood-based concussion diagnostic tool gets patent; examining the brain's electrical signals may be key to treating epilepsy, schizophrenia; machine-learning model may predict best antiseizure medications and more. Read the full coverage here: Neurolytixs secures US patent for blood-based concussion diagnostic tool Examination of brain's electrical signals may be key to treating e...
Neurology Edition: Top Headlines for Week of August 29, 2022 01.09.2022 12:33
In this edition, BMI is associated with dementia in women and linked with disease in men; Healthy diet, physical activity are linked to lower mortality in adults with PD; mild TBI and CT scans and more. Read the full coverage here: High BMI negatively associated with dementia in women, low BMI linked with disease in men Healthy diet, physical activity linked to lower mortality rate in adults with...
AMD/Retina Edition: Top Headlines for Week of August 29, 2022 31.08.2022 7:33
In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more. Association found between macular retinal nerve fiber layer thickness, cognitive decline FDA approves Cimerli as interchangeable biosimilar to Lucentis Black patients have higher ri...
Neurology Edition: Top Headlines for Week of August 22, 2022 25.08.2022 9:06
In this edition, leisure activities may lower risk for Alzheimer's disease and dementia; most common long COVID symptoms include fatigue and headache; 'life-changing' app-based digital therapeutic for tinnitus and more. Read the full coverage here: Leisure activities may lower risk for Alzheimer's disease, dementia Fatigue, headache most common long COVID symptoms Personalized, app-based digital t...
Neurology Edition: Top Headlines for Week of August 15, 2022 18.08.2022 10:45
In this edition, light stimulation may help delay Alzheimer's progression; sleep EEGs may predict future disease and mortality; updated data on the prevalence of tinnitus and more. Read the full coverage here: Light stimulation may help delay AD progression, more research needed in older adults Sleep EEGs may predict future disease, mortality Tinnitus affects more than 740 million adults globally...
Lung Cancer Edition: Top Headlines for Week of August 8, 2022 11.08.2022 11:42
In this edition, lung cancer risk is high among smokers for whom screening is not recommended; the role of circulating tumor DNA in lung cancer detection and treatment is 'exciting' for field; a subset of patients with lung cancer have poor response to COVID-19 vaccines, and more. Read the full coverage here: Lung cancer risk high among smokers for whom screening is not recommended Role of circula...
Neurology Edition: Top Headlines for Week of August 8, 2022 11.08.2022 9:42
In this edition, physicians should question patients with restless leg syndrome about cannabis use ; digital therapeutic improves symptoms of insomnia, anxiety and depression; more efficient sleep may benefit patients with fibromyalgia and insomnia and more. Read the full coverage here: Physicians should question patients with restless leg syndrome about cannabis use Digital therapeutic improves s...
Breast Cancer Edition: Top Headlines for Week of August 1, 2022 05.08.2022 10:03
In this episode, menopausal hormone therapy is not associated with breast cancer recurrence and mortality; pandemic-related screening declines may result in 'increased avoidable cancer deaths'; data on pertuzumab regimen in early breast cancer; and more. Read the full coverage here: Menopausal hormone therapy not associated with breast cancer recurrence, mortality Screening declines after pandemic...
Neurology Edition: Top Headlines for Week of August 1, 2022 04.08.2022 9:39
In this edition, temperature-controlled mattresses and pillows improve sleep; how overturning Roe v. Wade affects the field of neurology; college students' cognition altered by changing sleep patterns and more. Read the full coverage here: Temperature-controlled mattress, pillow improve sleep onset, quality Decision to overturn Roe v. Wade will 'undoubtedly' affect those in the field of neurology...
Neurology Edition: Top Headlines for Week of July 25, 2022 28.07.2022 8:31
In this week's edition, a Labcorp blood test identifies signs of neurodegenerative disease; the FDA approves an oral treatment for partial seizures in teens; ketamine shows efficacy in epilepsy; and more. Read the full coverage here: Labcorp blood test identifies signs of neurodegenerative disease FDA approves oral treatment for partial seizures in patients aged 16 years and older Ketamine effecti...
Neurology Edition: Top Headlines for July 18, 2022 21.07.2022 10:04
In this week's edition, Break Through Cancer awards $50M to fund a 'radical collaboration' in cancer research; the FDA grants a breakthrough device designation for an MS plasma test; App-based mental exercises may improve cognitive impairment; and more. Read the full coverage here: Break Through Cancer awards $50M to fund 'radical collaboration' in cancer research FDA grants breakthrough device de...
AMD/Retina Edition: Top Headlines for Week of July 18, 2022 21.07.2022 6:51
In this edition, Iveric Bio is given exclusive permission to develop, commercialize new formulations of Zimura; subretinal drusenoid deposits linked with cardiovascular disease; subcutaneous elamipretide may improve visual function in geographic atrophy; and more. Read the full coverage here: Iveric Bio given exclusive permission to develop, commercialize new formulations of Zimura Subretinal drus...
Lung Cancer Edition: Top Headlines for Week of July 11, 2022 13.07.2022 11:53
In this edition, Incidental respiratory findings on low-dose CT lung cancer screening common; lack of guideline-concordant treatment for early-stage non-small cell lung cancer common; women at greater risk for more severe adverse events from cancer treatments, and more. Read the full coverage here: Incidental respiratory findings on low-dose CT lung cancer screening common Lack of guideline-concor...
Neurology Edition: Top Headlines for Week of July 4, 2022 07.07.2022 9:47
In this week's edition, women are less likely than men to return to work after large vessel occlusion stroke; cognitive impairment, headaches and CVD are more common in former college football players; veterans, providers support the addition of integrative medicine for chronic headaches; and more. Read the full coverage here: Women less likely than men to return to work after large vessel occlusi...
Breast Cancer Edition: Top Headlines for Week of June 27, 2022 01.07.2022 13:43
In this edition, late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic; chemicals found in hair products increase viability of breast cancer cells in Black women; continued CDK 4/6 inhibition after breast cancer progression may benefit some patients; and more. Read the full coverage here: Late-stage colorectal, breast cancer diagnoses increase after start of COVI...
Neurology Edition: Top Headlines for Week of June 13, 2022 17.06.2022 8:53
In this week's edition, CAR-T 'robustly effective' in younger patients with deadly form of brain cancer; SARS-CoV-2 linked to range of neurological diseases; Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability; and more. Read the full coverage here: Steerable microcatheter nets FDA 510(k) clearance for neurologic, peripheral, coronary use CAR-T 'robustly effectiv...
Lung Cancer Edition: Top Headlines for Week of June 6, 2022 08.06.2022 10:34
In this edition, AYA cancer survivors are at higher risk for death due to second primary cancers; a radiation technique reduces symptomatic esophagitis in patients with advanced lung cancer; a phase 3 trial of tiragolumab plus atezolizumab misses its co-primary endpoint; and more. Read the full coverage here: AYA cancer survivors at higher risk for death due to second primary cancers Radiation tec...
Neurology Edition: Top Headlines for Week of May 30, 2022 01.06.2022 8:36
In this week's edition, anxiety, depression worse among older men with vision impairment; emerging therapeutics may improve outcomes in pediatric patients with rare disorders; glioblastoma presents roadblock to successful immunotherapy; and more. Read the full coverage here: MRI findings key pathology markers of 4R-tauopathies Emerging therapeutics may improve outcomes in pediatric patients with r...
AMD/Retina Edition: Top Headlines for Week of May 23, 2022 26.05.2022 8:01
Read the full coverage here: In this edition, diet, genetics and family history play role in AMD progression; omega-3 fatty acids may improve vision in dry AMD; long-term dopamine treatment may delay onset of diabetic retinopathy; and more. Diet, genetics and family history play role in AMD progression Omega-3 fatty acids may improve vision in dry AMD Long-term dopamine treatment may delay onset o...
Neurology Edition: Top Headlines for Week of May 16, 2022 19.05.2022 8:04
In this week's edition, childhood sexual and emotional abuse increases the risk for multiple sclerosis in women; fentanyl-related cardiac arrest is linked to worse neurological outcomes; Black patients with MS have a higher rate of disability compared with their white counterparts; and more. Read the full coverage here: Childhood sexual, emotional abuse increases multiple sclerosis risk in women F...
Lung Cancer Edition: Top Headlines for Week of May 9, 2022 13.05.2022 11:05
In this edition, early lung cancer detection improves survival rates; incidental respiratory findings on low-dose CT lung cancer screening common; certain patients may derive more benefit from immunotherapy for non-small cell lung cancer and more. Read the full coverage here: Early lung cancer detection improves survival rates Incidental respiratory findings on low-dose CT lung cancer screening co...
Neurology Edition: Top Headlines for Week of May 2, 2022 04.05.2022 10:24
In this week's edition, risk for cognitive decline is associated with older COVID-19 survivors; a study validates an FDA-approved blood test for traumatic brain injury; and more. Read the full coverage here: Risk for cognitive decline associated with older COVID-19 survivors Study validates FDA-approved blood test for traumatic brain injury VA hospital telestroke networks improve treatment, lower...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.